DK395289A - 13,17-propionsyre- og propionsyrederivatsubstituerede porfyrin-kompleksforbindelser, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem - Google Patents

13,17-propionsyre- og propionsyrederivatsubstituerede porfyrin-kompleksforbindelser, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem Download PDF

Info

Publication number
DK395289A
DK395289A DK395289A DK395289A DK395289A DK 395289 A DK395289 A DK 395289A DK 395289 A DK395289 A DK 395289A DK 395289 A DK395289 A DK 395289A DK 395289 A DK395289 A DK 395289A
Authority
DK
Denmark
Prior art keywords
propionic acid
complex compounds
porfyrine
procedures
substituted
Prior art date
Application number
DK395289A
Other languages
Danish (da)
English (en)
Other versions
DK395289D0 (da
Inventor
Ulrich Niedballa
Heinz Gries
Juergen Conrad
Ulrich Speck
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK395289D0 publication Critical patent/DK395289D0/da
Publication of DK395289A publication Critical patent/DK395289A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/803—Stabe free radicals, e.g. spin immunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK395289A 1988-08-13 1989-08-11 13,17-propionsyre- og propionsyrederivatsubstituerede porfyrin-kompleksforbindelser, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem DK395289A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3827940A DE3827940A1 (de) 1988-08-13 1988-08-13 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel

Publications (2)

Publication Number Publication Date
DK395289D0 DK395289D0 (da) 1989-08-11
DK395289A true DK395289A (da) 1990-02-14

Family

ID=6361054

Family Applications (1)

Application Number Title Priority Date Filing Date
DK395289A DK395289A (da) 1988-08-13 1989-08-11 13,17-propionsyre- og propionsyrederivatsubstituerede porfyrin-kompleksforbindelser, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem

Country Status (14)

Country Link
US (1) US5275801A (pt)
EP (1) EP0355041B1 (pt)
JP (1) JPH02160789A (pt)
AT (1) ATE128138T1 (pt)
DE (2) DE3827940A1 (pt)
DK (1) DK395289A (pt)
ES (1) ES2077577T3 (pt)
GR (1) GR3017586T3 (pt)
IE (1) IE70229B1 (pt)
IL (1) IL91292A0 (pt)
NO (1) NO172238C (pt)
NZ (1) NZ230288A (pt)
PT (1) PT91422B (pt)
ZA (1) ZA896187B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972307A (en) * 1989-10-23 1999-10-26 Nycomed Salutar, Inc. Dichelants
US5650133A (en) * 1990-01-19 1997-07-22 Nycomed Salutar Macrocyclic polyaza dichelates linked through ring nitrogens via an amide or ester functionality
US5679810A (en) * 1990-01-19 1997-10-21 Salutar, Inc. Linear oligomeric polychelant compounds
US5262532A (en) * 1991-07-22 1993-11-16 E.R. Squibb & Sons, Inc. Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging
DE4232925A1 (de) * 1992-09-28 1994-03-31 Diagnostikforschung Inst 3-,8-substituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel und Verfahren zu ihrer Herstellung
DE4303969B4 (de) * 1993-02-10 2006-01-19 Oped Gmbh Schuh, insbesondere Skischuh
DE4403789A1 (de) * 1994-02-03 1995-08-10 Schering Ag Mittel zur visuellen Markierung von Körpergewebe
DE4428874A1 (de) * 1994-08-08 1996-02-22 Schering Ag Dimere DTPA-Derivate und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel
WO2000000204A1 (en) * 1997-02-14 2000-01-06 Miravant Pharmaceuticals, Inc. Indium photosensitizers for pdt
US6194566B1 (en) * 1997-12-02 2001-02-27 Schering Aktiengesellschaft Process for the production of metalloporphyrin-metal complex conjugates
DE19845782C1 (de) * 1998-09-22 2000-04-13 Schering Ag Verfahren zur Herstellung von Metallporphyrin-Metallkomplex-Konjugaten
US6334995B1 (en) * 1998-03-24 2002-01-01 Council Of Scientific & Industrial Research Process for the preparation of technetium-99m diethylene triamine penta-acetic acid diester
US6136841A (en) * 1998-06-02 2000-10-24 Schering Aktiengesellschaft 3-, 8-substituted deuteroporphyrin derivatives, pharmaceutical agents that contain the latter, process for their production and their use in photodynamic therapy and MRI diagnosis
DE19825512A1 (de) * 1998-06-02 1999-12-09 Schering Ag 3-,8-subsituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung in der photodynamischen Therapie und MRI-Diagnostik
AU748625B2 (en) * 1998-07-10 2002-06-06 Meiji Seika Kaisha Ltd. Novel X-ray intercepting metal complexes of chlorin derivatives
DE19835082A1 (de) * 1998-07-24 2000-02-03 Schering Ag Paramagnetische 3-,8-substituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung für das Nekrose- und Infarkt-MR-Imaging
US6251367B1 (en) 1998-07-24 2001-06-26 Schering Aktiengesellschaft Paramagnetic 3-,8-substituted deuteroporphyrin derivatives, pharmaceutical agents that contain the latter, process for their production, and their use for MR imaging of necrosis and infarction
FI982422A0 (fi) 1998-11-09 1998-11-09 Arctic Diagnostics Oy Porfyriiniyhdisteitä, niiden konjugaatit sekä määritysmenetelmiä pohjautuen näiden konjugaattien käyttöön
AU4679900A (en) * 1999-04-30 2000-11-17 Slil Biomedical Corporation Conformationally restricted polyamine analogs as disease therapies
EP1148057A4 (en) * 1999-11-30 2002-05-29 Photochemical Co Ltd PORPHYRIN COMPLEX SUPPORTING A NITROIMIDAZOLE
US6605090B1 (en) * 2000-10-25 2003-08-12 Sdgi Holdings, Inc. Non-metallic implant devices and intra-operative methods for assembly and fixation
WO2002048154A2 (en) * 2000-12-15 2002-06-20 Mitokor Cobalt-porphyrin complexes and use thereof as an anti-obesity agent
US7048907B2 (en) * 2001-02-05 2006-05-23 Biophysics Assay Laboratory, Inc. Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products
EP1401430A4 (en) * 2001-05-31 2005-10-19 Miravant Pharm Inc SUBSTITUTED PORPHYRIN AND AZAPORPHYRIN DERIVATIVES AND USE IN PHOTODYNAMIC THERAPY, RADIOIMAGING, AND MRI DIAGNOSIS
US7375216B2 (en) * 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
US7026347B2 (en) * 2002-06-26 2006-04-11 Cellgate, Inc. Porphyrin-polyamine conjugates for cancer therapy
US20040127479A1 (en) * 2002-08-27 2004-07-01 Merck Patent Gmbh Peroxynitrite rearrangement catalysts
DE10240343A1 (de) * 2002-08-27 2004-03-11 Schering Ag Peroxynitrit-Umlagerungskatalysatoren
US20040097481A1 (en) * 2002-11-20 2004-05-20 Benjamin Levinson Water-soluble mesoporphyrin compounds and methods of preparation
US20060222668A1 (en) * 2005-04-01 2006-10-05 Wellspring Pharmaceutical Corporation Stannsoporfin compositions, drug products and methods of manufacture
US7960371B2 (en) * 2006-10-04 2011-06-14 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
US8735574B2 (en) 2011-03-30 2014-05-27 Infacare Pharmaceutical Corporation Methods for synthesizing metal mesoporphyrins
CN102363619A (zh) * 2011-11-18 2012-02-29 中国医学科学院生物医学工程研究所 水溶性原卟啉化合物及制备方法及用途
CN115894301B (zh) * 2022-10-25 2024-08-13 武汉大学中南医院 一种二聚化钆基t1磁共振对比造影剂及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5156840A (en) * 1982-03-09 1992-10-20 Cytogen Corporation Amine-containing porphyrin derivatives
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
WO1986001720A1 (en) * 1984-09-13 1986-03-27 Cytogen Corporation Antibody therapeutic agent conjugates
US4986256A (en) * 1985-02-28 1991-01-22 The United States Of America As Represented By The Department Of Health And Human Services Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
AU603999B2 (en) * 1985-10-23 1990-12-06 Photochemical Co., Ltd. Porphyrin derivatives, and their production and use
US4923437A (en) * 1986-07-18 1990-05-08 Gordon Robert T Process for applying a localized magnetic or electric field
US4882234A (en) * 1986-11-12 1989-11-21 Healux, Inc. Storage-stable porphin compositions and a method for their manufacture
JPH0786109B2 (ja) * 1987-12-21 1995-09-20 浜理薬品工業株式会社 フェオフォルバイド誘導体
US5004811A (en) * 1987-12-24 1991-04-02 Nippon Petrochemicals Company, Ltd. Tetrapyrrole aminocarboxylic acids
EP0350948B1 (en) * 1988-07-14 1998-03-18 Toyohakka Kogyo Kabushiki Kaisha Porphyrin derivatives

Also Published As

Publication number Publication date
EP0355041A2 (de) 1990-02-21
IL91292A0 (en) 1990-03-19
NO893245D0 (no) 1989-08-11
AU3957089A (en) 1990-02-15
DK395289D0 (da) 1989-08-11
GR3017586T3 (en) 1995-12-31
EP0355041A3 (de) 1991-07-24
IE70229B1 (en) 1996-11-13
DE58909444D1 (de) 1995-10-26
AU622470B2 (en) 1992-04-09
PT91422B (pt) 1995-05-31
EP0355041B1 (de) 1995-09-20
NO172238B (no) 1993-03-15
US5275801A (en) 1994-01-04
DE3827940A1 (de) 1990-03-01
ES2077577T3 (es) 1995-12-01
ATE128138T1 (de) 1995-10-15
ZA896187B (en) 1990-05-30
PT91422A (pt) 1990-03-08
IE892605L (en) 1990-02-13
NZ230288A (en) 1992-06-25
NO172238C (no) 1993-06-23
NO893245L (no) 1990-02-14
JPH02160789A (ja) 1990-06-20

Similar Documents

Publication Publication Date Title
DK395289A (da) 13,17-propionsyre- og propionsyrederivatsubstituerede porfyrin-kompleksforbindelser, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
DK132889A (da) Meso-tetraphenyl-kompleksforbindelser, fremgangsmaade til fremstilling deraf og farmaceutiske midler, der indeholder dem
DK0430863T3 (da) Kaskadepolymer-bundne kompleksdannere, komplekser og konjugater deraf, fremgangsmåde til deres fremstilling og farmaceutiske midler der indeholder dem
NO914356L (no) Mono n-substituerte 1,4,7,10-tetraazacyklododekanderivater, fremgangsmaater for fremstilling av dem og farmasoeytiskemidler som inneholder dem
NO890832D0 (no) Polymerbundne kompleksdannere, deres komplekser og konjugater, fremgangsmaater for fremstilling av disse, og farmasoeytiske midler inneholdende disse.
DK0496378T3 (da) Biphenylderivater, lægemidler indeholdende disse forbindelser og fremgangsmåder til deres fremstilling
RU94022254A (ru) Лиганды, содержащие гетероатом, их комплексы с металлами, способ получения, способ лечения и применение в диагностических наборах
NO930517L (no) Benzimidazolylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
NO880443D0 (no) N-heterosyklisk-n-(4-piperidyl)amider og farmasoeytiske preparater og fremgangsmaater for bruk av slike forbindelser.
NO932120L (no) Bifenylderivater, legemidler inneholdende disse, og fremgangsmaate for deres fremstilling
DK498988A (da) 3,7-diazabicyclooe3,3,1aanonan-forbindelser, fremgangsmaade til deres fremstilling og hjertevirksomme laegemidler indeholdende disse